Press contact

Communication Service

Phone : +33(0) 362 263 772

E-mail : This email address is being protected from spambots. You need JavaScript enabled to view it.

Nos communiqués de presse

  • 18/10/2022: GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis pdfENG
  • 30/03/2021: Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis pdfENG
  • 24/03/2021: Deeplex® Myc-TB, a breakthrough innovation to effectively fight tuberculosis pdfFR pdfENG
  • 17/11/2020: A microbial signature in indoor air associated with severe asthma pdfFR pdfENG
  • 05/11/2020: Number of new cases in contacts of leprosy patients decreases after dose of antibiotic pdfFR pdfENG
  • 02/11/2020: Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance pdfFR pdfENG
  • 09/06/2020: Tuberculosis: discovery of an ancestral lineage in the African Great Lakes region pdfFR pdfENG
  • 24/03/2020: GenoScreen launches a rapid, effective diagnostic kit, to combat tuberculosis antibiotic resistance pdfFR pdfENG
  • 03/03/2020: (French) Grippe : lutter contre les surinfections bactériennes grâce au microbiote pdfFR
  • 28/01/2019: GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion pdfFR pdfENG
  • 25/10/2018: A major advance in the fight against multidrug-resistant tuberculosis pdfFR pdfENG
By continuing your visit to this site, you accept the use of statistics cookies